| 171 | Hepcidin-25 negatively predicts left ventricular mass index in chronic kidney disease patients |
| 172 | Hepatocellular carcinoma in patients with chronic kidney disease |
| 173 | Urgent call for reconsideration of chronic kidney disease |
| 174 | Hepcidin and HFE protein: Iron metabolism as a target for the anemia of chronic kidney disease |
| 175 | Chronic kidney disease in acute coronary syndromes |
| 176 | Prophylaxis of chronic kidney disease after liver transplantation - experience from west China |
| 177 | Arterial stiffness, vascular calcification and bone metabolism in chronic kidney disease |
| 178 | Statins as antifungal agents |
| 179 | MRI-determined fat content of human liver, pancreas and kidney |
| 180 | Do statins reduce hepatitis C RNA titers during routine clinical use? |
| © 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |